FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CTNND2-POLR1A

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CTNND2-POLR1A
FusionPDB ID: 20398
FusionGDB2.0 ID: 20398
HgeneTgene
Gene symbol

CTNND2

POLR1A

Gene ID

1501

25885

Gene namecatenin delta 2RNA polymerase I subunit A
SynonymsGT24|NPRAPA190|AFDCIN|RPA1|RPA194|RPO1-4|RPO14
Cytomap

5p15.2

2p11.2

Type of geneprotein-codingprotein-coding
Descriptioncatenin delta-2T-cell delta-catenincatenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)neurojunginDNA-directed RNA polymerase I subunit RPA1DNA-directed RNA polymerase I largest subunitDNA-directed RNA polymerase I subunit ADNA-directed RNA polymerase I subunit A1RNA polymerase I 194 kDa subunitpolymerase (RNA) I polypeptide A, 194kDapolymerase
Modification date2020032020200313
UniProtAcc

Q9UQB3

Main function of 5'-partner protein: FUNCTION: Has a critical role in neuronal development, particularly in the formation and/or maintenance of dendritic spines and synapses (PubMed:25807484). Involved in the regulation of Wnt signaling (PubMed:25807484). It probably acts on beta-catenin turnover, facilitating beta-catenin interaction with GSK3B, phosphorylation, ubiquitination and degradation (By similarity). Functions as a transcriptional activator when bound to ZBTB33 (By similarity). May be involved in neuronal cell adhesion and tissue morphogenesis and integrity by regulating adhesion molecules. {ECO:0000250|UniProtKB:O35927, ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:9971746}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000304623, ENST00000359640, 
ENST00000458100, ENST00000495388, 
ENST00000503622, ENST00000511377, 
ENST00000483538, ENST00000263857, 
ENST00000409681, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score14 X 13 X 7=12744 X 5 X 4=80
# samples 155
** MAII scorelog2(15/1274*10)=-3.08633087176042
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/80*10)=-0.678071905112638
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CTNND2 [Title/Abstract] AND POLR1A [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CTNND2 [Title/Abstract] AND POLR1A [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CTNND2(11732248)-POLR1A(86257519), # samples:1
Anticipated loss of major functional domain due to fusion event.CTNND2-POLR1A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CTNND2-POLR1A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:11732248/chr2:86257519)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CTNND2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across POLR1A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000304623CTNND2chr511732248-ENST00000263857POLR1Achr286257519-8156364190948252
ENST00000304623CTNND2chr511732248-ENST00000409681POLR1Achr286257519-2044364190948252
ENST00000359640CTNND2chr511732248-ENST00000263857POLR1Achr286257519-8111319145903252
ENST00000359640CTNND2chr511732248-ENST00000409681POLR1Achr286257519-1999319145903252

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000304623ENST00000263857CTNND2chr511732248-POLR1Achr286257519-0.0037339510.99626607
ENST00000304623ENST00000409681CTNND2chr511732248-POLR1Achr286257519-0.0058409990.994159
ENST00000359640ENST00000263857CTNND2chr511732248-POLR1Achr286257519-0.0036726150.99632734
ENST00000359640ENST00000409681CTNND2chr511732248-POLR1Achr286257519-0.0060983910.9939016

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CTNND2-POLR1A

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CTNND2chr511732248POLR1Achr28625751931957TETTSAILASVKEQVTVKLPLMKINF
CTNND2chr511732248POLR1Achr28625751936457TETTSAILASVKEQVTVKLPLMKINF

Top

Potential FusionNeoAntigen Information of CTNND2-POLR1A in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CTNND2-POLR1A_11732248_86257519.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CTNND2-POLR1Achr511732248chr286257519364HLA-B47:01KEQVTVKL0.99770.57411119
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:13KEQVTVKL0.97180.91971119
CTNND2-POLR1Achr511732248chr286257519364HLA-A30:08SVKEQVTVK0.99790.6885918
CTNND2-POLR1Achr511732248chr286257519364HLA-B14:02EQVTVKLPL0.99350.59671221
CTNND2-POLR1Achr511732248chr286257519364HLA-B14:01EQVTVKLPL0.99350.59671221
CTNND2-POLR1Achr511732248chr286257519364HLA-B45:01KEQVTVKLP0.99130.59361120
CTNND2-POLR1Achr511732248chr286257519364HLA-B50:02KEQVTVKLP0.98660.51551120
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:01EQVTVKLPL0.98150.80511221
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:01VKEQVTVKL0.97710.84411019
CTNND2-POLR1Achr511732248chr286257519364HLA-B38:02VKEQVTVKL0.96720.95271019
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:13VKEQVTVKL0.93740.88271019
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:24VKEQVTVKL0.9350.50041019
CTNND2-POLR1Achr511732248chr286257519364HLA-B41:01KEQVTVKLP0.66030.69991120
CTNND2-POLR1Achr511732248chr286257519364HLA-B15:10VKEQVTVKL0.56370.76491019
CTNND2-POLR1Achr511732248chr286257519364HLA-B50:01KEQVTVKLP0.32630.72341120
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:22AILASVKEQV0.99050.6793515
CTNND2-POLR1Achr511732248chr286257519364HLA-A30:08ASVKEQVTVK0.97880.7167818
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:22ILASVKEQVTV0.99960.6979617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:60ILASVKEQVTV0.99870.697617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:24ILASVKEQVTV0.99860.6405617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:30ILASVKEQVTV0.99860.6405617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:27ILASVKEQVTV0.99860.6959617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:67ILASVKEQVTV0.99860.6405617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:19ILASVKEQVTV0.99530.6012617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:29ILASVKEQVTV0.97320.644617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:35ILASVKEQVTV0.96250.6746617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:20ILASVKEQVTV0.95310.65617
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:08KEQVTVKL0.98460.81381119
CTNND2-POLR1Achr511732248chr286257519364HLA-C15:06ASVKEQVTV0.99980.7885817
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:09VKEQVTVKL0.9840.70371019
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:12EQVTVKLPL0.96250.81451221
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:05EQVTVKLPL0.96160.77231221
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:05VKEQVTVKL0.93530.84311019
CTNND2-POLR1Achr511732248chr286257519364HLA-C07:13VKEQVTVKL0.92760.91041019
CTNND2-POLR1Achr511732248chr286257519364HLA-C02:06ASVKEQVTV0.84670.913817
CTNND2-POLR1Achr511732248chr286257519364HLA-B14:03EQVTVKLPL0.70230.74211221
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:08VKEQVTVKL0.5870.84031019
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:02AILASVKEQV0.99110.523515
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:02ILASVKEQVTV0.99960.5019617
CTNND2-POLR1Achr511732248chr286257519364HLA-A02:01ILASVKEQVTV0.99860.6405617
CTNND2-POLR1Achr511732248chr286257519364HLA-B40:04KEQVTVKL0.99950.64121119
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:02KEQVTVKL0.96480.91921119
CTNND2-POLR1Achr511732248chr286257519364HLA-C15:02ASVKEQVTV0.99980.8147817
CTNND2-POLR1Achr511732248chr286257519364HLA-C15:05ASVKEQVTV0.99980.8926817
CTNND2-POLR1Achr511732248chr286257519364HLA-A30:01SVKEQVTVK0.99770.7399918
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:02VKEQVTVKL0.97870.87291019
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:31EQVTVKLPL0.97780.80131221
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:31VKEQVTVKL0.97470.84481019
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:02EQVTVKLPL0.97460.82631221
CTNND2-POLR1Achr511732248chr286257519364HLA-B39:11VKEQVTVKL0.65770.75851019
CTNND2-POLR1Achr511732248chr286257519364HLA-B15:09VKEQVTVKL0.59170.55091019
CTNND2-POLR1Achr511732248chr286257519364HLA-B50:04KEQVTVKLP0.32630.72341120
CTNND2-POLR1Achr511732248chr286257519364HLA-B50:05KEQVTVKLP0.32630.72341120
CTNND2-POLR1Achr511732248chr286257519364HLA-A30:01ASVKEQVTVK0.97860.7637818

Top

Potential FusionNeoAntigen Information of CTNND2-POLR1A in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CTNND2-POLR1A_11732248_86257519.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CTNND2-POLR1Achr511732248chr286257519364DRB1-0324TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1113TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1117TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1117TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1117ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1117SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1152TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1152TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1152ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1152SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1189TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1189TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1189ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1331TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1377TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1401TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1401TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1401ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1401SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1404TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1404TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1404ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1404SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1405TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1405TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1405ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1405SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1407TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1407TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1407ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1408TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1408TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1408ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1408SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1411TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1411TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1411ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1414TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1414TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1416TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1418TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1418TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1418ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1418SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1423TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1423TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1423ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1423SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1426TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1426TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1426ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1426SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1428TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1428TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1428ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1428SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1429TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1431TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1431TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1431ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1432TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1432TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1432ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1433TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1434TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1434TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1435TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1435TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1435ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1435SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1436TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1436TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1438TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1438TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1438ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1438SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1439TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1439TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1439ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1439SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1442TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1442TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1443TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1443TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1443ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1443SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1444TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1444TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1445TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1445TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1445ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1445SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1450TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1450TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1450ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1450SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1454TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1454TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1454ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1454SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1455TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1455TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1455ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1456TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1456TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1456ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1456SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1458TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1458TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1458ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1458SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1459TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1459TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1459ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1459SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1460TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1460TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1460ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1460SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1461TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1461TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1461ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1461SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1462TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1462TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1462ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1462SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1464TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1464TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1464ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1464SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1465TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1465TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1468TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1468TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1468ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1470TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1470TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1470ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1470SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1471TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1471TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1471ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1471SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1472TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1472TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1472ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1472SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1473TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1475TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1475TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1475ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1475SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1481TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1481TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1482TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1482TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1482ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1482SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1486TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1486TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1486ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1486SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1487TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1487TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1487ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1487SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1488TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1488TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1488ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1488SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1490TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1490TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1490ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1490SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1491TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1491TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1491ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1491SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1493TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1493TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1493ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1495TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1495TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1495ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1495SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1496TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1496TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1496ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1496SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1497TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1497TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1497ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1497SAILASVKEQVTVKL419
CTNND2-POLR1Achr511732248chr286257519364DRB1-1499TSAILASVKEQVTVK318
CTNND2-POLR1Achr511732248chr286257519364DRB1-1499TTSAILASVKEQVTV217
CTNND2-POLR1Achr511732248chr286257519364DRB1-1499ETTSAILASVKEQVT116
CTNND2-POLR1Achr511732248chr286257519364DRB1-1499SAILASVKEQVTVKL419

Top

Fusion breakpoint peptide structures of CTNND2-POLR1A

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3778ILASVKEQVTVKLPCTNND2POLR1Achr511732248chr286257519364

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CTNND2-POLR1A

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3778ILASVKEQVTVKLP-7.9962-8.1096
HLA-B14:023BVN3778ILASVKEQVTVKLP-5.70842-6.74372
HLA-B52:013W393778ILASVKEQVTVKLP-6.83737-6.95077
HLA-B52:013W393778ILASVKEQVTVKLP-4.4836-5.5189
HLA-A11:014UQ23778ILASVKEQVTVKLP-10.0067-10.1201
HLA-A11:014UQ23778ILASVKEQVTVKLP-9.03915-10.0745
HLA-A24:025HGA3778ILASVKEQVTVKLP-6.56204-6.67544
HLA-A24:025HGA3778ILASVKEQVTVKLP-5.42271-6.45801
HLA-B44:053DX83778ILASVKEQVTVKLP-7.85648-8.89178
HLA-B44:053DX83778ILASVKEQVTVKLP-5.3978-5.5112
HLA-A02:016TDR3778ILASVKEQVTVKLP-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of CTNND2-POLR1A

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CTNND2-POLR1Achr511732248chr2862575191019VKEQVTVKLAAAGAACAGGTGACAGTGAAGCTCCCT
CTNND2-POLR1Achr511732248chr2862575191119KEQVTVKLGAACAGGTGACAGTGAAGCTCCCT
CTNND2-POLR1Achr511732248chr2862575191120KEQVTVKLPGAACAGGTGACAGTGAAGCTCCCTCTG
CTNND2-POLR1Achr511732248chr2862575191221EQVTVKLPLCAGGTGACAGTGAAGCTCCCTCTGATG
CTNND2-POLR1Achr511732248chr286257519515AILASVKEQVATCCTCGCCTCAGTCAAAGAACAGGTGACA
CTNND2-POLR1Achr511732248chr286257519617ILASVKEQVTVCTCGCCTCAGTCAAAGAACAGGTGACAGTGAAG
CTNND2-POLR1Achr511732248chr286257519817ASVKEQVTVTCAGTCAAAGAACAGGTGACAGTGAAG
CTNND2-POLR1Achr511732248chr286257519818ASVKEQVTVKTCAGTCAAAGAACAGGTGACAGTGAAGCTC
CTNND2-POLR1Achr511732248chr286257519918SVKEQVTVKGTCAAAGAACAGGTGACAGTGAAGCTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CTNND2-POLR1Achr511732248chr286257519116ETTSAILASVKEQVTACCACCTCTGCCATCCTCGCCTCAGTCAAAGAACAGGTGACAGTG
CTNND2-POLR1Achr511732248chr286257519217TTSAILASVKEQVTVACCTCTGCCATCCTCGCCTCAGTCAAAGAACAGGTGACAGTGAAG
CTNND2-POLR1Achr511732248chr286257519318TSAILASVKEQVTVKTCTGCCATCCTCGCCTCAGTCAAAGAACAGGTGACAGTGAAGCTC
CTNND2-POLR1Achr511732248chr286257519419SAILASVKEQVTVKLGCCATCCTCGCCTCAGTCAAAGAACAGGTGACAGTGAAGCTCCCT

Top

Information of the samples that have these potential fusion neoantigens of CTNND2-POLR1A

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SKCMCTNND2-POLR1Achr511732248ENST00000304623chr286257519ENST00000263857TCGA-D3-A2JC-06A

Top

Potential target of CAR-T therapy development for CTNND2-POLR1A

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CTNND2-POLR1A

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CTNND2-POLR1A

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource